These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35757769)

  • 1. Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill
    Singh VK; Khan A; Xu Y; Mai S; Zhang L; Mishra A; Restrepo BI; Pan PY; Chen SH; Jagannath C
    Front Immunol; 2022; 13():865503. PubMed ID: 35757769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
    Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
    Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
    J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
    Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
    Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
    Namdev P; Patel S; Sparling B; Garg A
    Front Immunol; 2021; 12():647019. PubMed ID: 33995365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
    Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
    Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells.
    John V; Kotze LA; Ribechini E; Walzl G; Du Plessis N; Lutz MB
    Front Immunol; 2019; 10():2826. PubMed ID: 31849990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
    Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
    Front Immunol; 2021; 12():676679. PubMed ID: 34149712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Monocytic Suppressive Cells Promote Replication of
    Agrawal N; Streata I; Pei G; Weiner J; Kotze L; Bandermann S; Lozza L; Walzl G; du Plessis N; Ioana M; Kaufmann SHE; Dorhoi A
    Front Immunol; 2018; 9():2417. PubMed ID: 30405617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.
    Radandish M; Khalilian P; Esmaeil N
    Front Immunol; 2021; 12():667705. PubMed ID: 34489926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.
    Du Plessis N; Jacobs R; Gutschmidt A; Fang Z; van Helden PD; Lutz MB; Hesseling AC; Walzl G
    Eur J Immunol; 2017 Jan; 47(1):107-118. PubMed ID: 27861788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages.
    Dabla A; Liang YC; Rajabalee N; Irwin C; Moonen CGJ; Willis JV; Berton S; Sun J
    mBio; 2022 Aug; 13(4):e0145622. PubMed ID: 35924849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
    Stiff A; Trikha P; Mundy-Bosse B; McMichael E; Mace TA; Benner B; Kendra K; Campbell A; Gautam S; Abood D; Landi I; Hsu V; Duggan M; Wesolowski R; Old M; Howard JH; Yu L; Stasik N; Olencki T; Muthusamy N; Tridandapani S; Byrd JC; Caligiuri M; Carson WE
    Clin Cancer Res; 2018 Apr; 24(8):1891-1904. PubMed ID: 29363526
    [No Abstract]   [Full Text] [Related]  

  • 15. Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of
    Rao Muvva J; Parasa VR; Lerm M; Svensson M; Brighenti S
    Front Immunol; 2019; 10():3157. PubMed ID: 32038652
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
    du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
    Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.
    Wang Q; Lu Y; Li R; Jiang Y; Zheng Y; Qian J; Bi E; Zheng C; Hou J; Wang S; Yi Q
    Leukemia; 2018 Jan; 32(1):176-183. PubMed ID: 28626216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.
    Su MT; Kumata S; Endo S; Okada Y; Takai T
    Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice.
    Singh VK; Chau E; Mishra A; DeAnda A; Hegde VL; Sastry JK; Haviland D; Jagannath C; Godin B; Khan A
    J Control Release; 2022 Sep; 349():796-811. PubMed ID: 35914613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors.
    Umiker B; Hashambhoy-Ramsay Y; Smith J; Rahman T; Mueller A; Davidson R; Meyer C; Patankar G; Alam MM; Jaffe S; Krukenberg K; Goodman A; Spaulding V; Priess M; Dhaneshwar A; Wong M; Diiorio A; O'Malley K; McGrath L; Willer M; Pepper L; Gostissa M; Kis-Toth K; Wiederschain D; Cohen H; Shaffer DR
    Mol Cancer Ther; 2023 Apr; 22(4):471-484. PubMed ID: 36780212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.